黄素和肠道微生物群:讲述概述,重点关注血糖控制
Simona Servida1, Alessandra Piontini1, Francesca Gori2
1Obesity and Work Centre, Occupational Medicine Unit, Clinica del Lavoro L. Devoto, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, 20122 Milan, Italy.
International journal of molecular sciences
|July 27, 2024
概括
来自黄的黄素对肠道微生物群 (GM) 有影响,可能治疗2型糖尿病等代谢疾病. 恢复转基因平衡可能会改善血糖控制并减少炎症.
科学领域:
- 药理学和微生物学 药理学和微生物学
- 代谢性疾病研究研究
背景情况:
- 黄含有黄素,研究的抗氧化,抗炎和抗糖尿病特性.
- 黄素具有较低的生物利用性,但与肠道中的肠道微生物群 (GM) 相互作用.
- 肠道微生物群在宿主健康和代谢调节中发挥着关键作用.
研究的目的:
- 为了总结黄素的生物特性.
- 专注于黄素与肠道微生物群的联系.
- 探索黄素在预防和治疗代谢性疾病方面的潜在作用.
主要方法:
- 临床前和临床研究的文献综述.
- 对黄素与肠道微生物群相互作用的分析.
- 检查肠道微生物群在葡萄糖和脂质代谢中的作用.
主要成果:
- 黄素的低血糖作用与代谢性疾病中改变的肠道失调有关.
- 恢复ebiotic转基因可能有助于血糖平衡.
- 肠道微生物群参与调节葡萄糖和脂质新陈代谢,与胰岛素抵抗和炎症相关的失生症.
结论:
- 黄素与肠道微生物群的相互作用是其对代谢性疾病潜在治疗作用的关键因素.
- 用黄素准肠道微生物群可能为管理代谢障碍提供一种新的策略.
- 需要进一步的研究,以充分阐明在代谢健康中黄素-转基因相互作用背后的机制.
相关概念视频
What is Monogastric Digestion?
71.0K
The human body contains a monogastric digestive system. In a monogastric digestive system, the stomach only contains one chamber in which it digests food. Several other animal species also have monogastric digestive systems, including pigs, horses, dogs, and birds. This chapter, however, focuses on the human digestive system.
71.0K
Bacterial Flora of the Large Intestine
408
The gut microbiome is formed by a vast and diverse community of bacteria that colonizes our large intestine. These bacteria start residing in the gut from birth and continue diversifying throughout life, influenced by factors such as diet, lifestyle, and stress. The gut bacterial community also includes bacteria from food and those that enter the colon through the anus.
The normal gut flora of the colon plays a critical role in generating essential vitamins such as vitamins K, B5, and B7.
The normal gut flora of the colon plays a critical role in generating essential vitamins such as vitamins K, B5, and B7.
408
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
168
α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are...
Acarbose and miglitol are...
168
Glucagon-like Receptor Agonists
312
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
312
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
331
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
331
Oral Hypoglycemic Agents: Biguanides and Glitazones
186
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
186


